Validation of trabectedin efficacy in patients with advanced soft tissue sarcoma
2 Views
administrator
07/18/23
Dr Axel Le Cesne, oncologist, sarcoma expert at Gustave Roussy, presents at ASCO 2018 the results of the T-SAR trial, comparing trabectedin vs best supportive care in patients with pretreated advanced soft tissue sarcoma.
-
Category
Show more
Facebook Comments
No comments found